The previous use of a controller medication was lower than expected in patients who were started on an LABA within this managed care population. The overall frequency of the prescribing of ...

Background: Current guidelines recommend the use of inhaled corticosteroids (ICSs) added to long-acting β 2-agonists (LABAs ... of LABAs/ICSs compared with LABA monotherapy for patients with ...

Enerzair (formerly QVM149) consists of long-acting beta agonist (LABA) indacaterol, long-acting muscarinic antagonist (LAMA) glycopyrronium, and inhaled corticosteroid (ICS) mometasone furoate ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

Over the last 10 years, the long-acting beta-agonists (LABAs) have become an important add-on therapy for the management of asthma, and they are now often used with ICS in a single ICS/LABA ...

The Salford study recruited a total of 4,233 patients who were taking inhaled corticosteroid (ICS) with or without a long acting beta 2-agonist (LABA) were randomised to receive either FF/VI or to ...

Respiratory nurse lead Carol Stonham outlines what nurses in primary care need to know about changes in the diagnosis and ...

New research into the use of beta agonists released this week raises concerns about the animal health and welfare of feedlot cattle. The peer-reviewed article, while acknowledging “significant ...

with and without an added long-acting β-agonist (LABA). The identified signatures were then associated with longitudinal clinical variables after treatment. Differential gene expression and cellular ...